Clinical trial

A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354

NCT00638989

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-04-11

PhasePHASE1

Study timeline

Study start (actual)2008-04-11Date precision: day

Registry last updated2017-05-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Healthyunresolved

Interventions

CAT-354 150 mg (intravenous)BIOLOGICAL

CAT-354 150 mg (subcutaneous)BIOLOGICAL

CAT-354 300 mg (subcutaneous)BIOLOGICAL

Sponsors & collaborators

MedImmune LLClead sponsor

Mapped research locations

LincolnNebraska, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00638989 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.